L056-0053 Screening compound: N-{[1-(4-chlorobenzoyl)-2,3-dihydro-1H-indol-6-yl]methyl}-2-cyclohexylacetamide

L056-0053 Screening compound: N-{[1-(4-chlorobenzoyl)-2,3-dihydro-1H-indol-6-yl]methyl}-2-cyclohexylacetamide
L056-0053 Screening compound: N-{[1-(4-chlorobenzoyl)-2,3-dihydro-1H-indol-6-yl]methyl}-2-cyclohexylacetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound L056-0053
N-{[1-(4-chlorobenzoyl)-2,3-dihydro-1H-indol-6-yl]methyl}-2-cyclohexylacetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L056-0053

Molecular Formula

C24H27ClN2O2 (C24 H27 ClN2 O2)

Compound Name

N-{[1-(4-chlorobenzoyl)-2,3-dihydro-1H-indol-6-yl]methyl}-2-cyclohexylacetamide

IUPAC name

N-{[1-(4-chlorobenzoyl)-23-dihydro-1H-indol-6-yl]methyl}-2-cyclohexylacetamide

SMILES

O=C(CC1CCCCC1)NCc1cc(N(CC2)C(c(cc3)ccc3Cl)=O)c2cc1

MDL Number (MFCD)

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

410.94

Hydrogen Bond Acceptors Count

4.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

4

Partition Coefficient, logP

5.085

Distribution Coefficient, logD

5.085

Water Solubility, LogSw

-5.59

Polar Surface Area

40.309

Acid Dissociation Constant (pKa)

12.64

Base Dissociation Constant (pKb)

-0.17

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

41.70

L056-0053 in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

GPCR Targeted Library (31838 compounds)

Adenosine Receptors Targeted Library (19896 compounds)

Epigenetics Focused Set (26518 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Cancer
  • Digestive system
  • Respiratory tract
  • Nervous system
  • Eye
  • Cardiovascular
Targets:
  • GPCR
  • GPCR
Mechanism of action:
  • Receptor's ligands
  • Receptor's ligands

References: we are preparing a list of scientific research reports with L056-0053 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L056-0053?
Check Price and Availability of L056-0053, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L056-0053 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L056-0053
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L056-0053
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L056-0053 available by request